Compounds, compositions, and methods for increasing CFTR activity
US10899751B2 · kind B2 · utility
1Cited by
19References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2017 |
| Grant date | Jan 26, 2021 |
| Priority date | — |
| Expiry date | Jun 21, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to disclosed compounds that increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.